Understanding antinuclear antibodies
- PMID: 1874653
Understanding antinuclear antibodies
Abstract
The American College of Rheumatology (formerly the American Rheumatism Association) diagnostic criteria for connective tissue disorders frequently include positive antinuclear antibody (ANA) assays. Proper interpretation of these tests requires an understanding of the principles governing ANA assays. Assay results are reported in two ways: as titers and as descriptions of fluorescent patterns. A titer is a quantitative measure of ANAs in serum. Different patterns of immunofluorescence are associated with different subsets of collagen vascular disease. Positive results can occur in the absence of connective tissue disease. Accurate diagnosis of connective tissue disorders requires judicious use of ANA assays as well as skillful interpretation of the results.
Similar articles
-
Performance of antinuclear antibody connective tissue disease screen.Ann N Y Acad Sci. 2007 Aug;1109:322-9. doi: 10.1196/annals.1398.038. Ann N Y Acad Sci. 2007. PMID: 17785321 Clinical Trial.
-
The clinical significance of antinuclear antibodies in connective tissue disease.Wien Klin Wochenschr. 1998 May 8;110(9):338-41. Wien Klin Wochenschr. 1998. PMID: 9629626
-
[Antinuclear antibodies in rheumatology].Z Rheumatol. 1994 Nov-Dec;53(6):327-34. Z Rheumatol. 1994. PMID: 7871904 Review. German.
-
[Diagnostic value of antinuclear and anti-native-DNA antibodies in connective tissue diseases].Rev Med Chil. 1982 Jan;110(1):24-8. Rev Med Chil. 1982. PMID: 6760312 Spanish. No abstract available.
-
Antinuclear antibodies in dermatology.Semin Cutan Med Surg. 2001 Mar;20(1):2-13. doi: 10.1053/sder.2001.23089. Semin Cutan Med Surg. 2001. PMID: 11308133 Review.
MeSH terms
Substances
LinkOut - more resources
Medical